HIV

Adolescents who are treatment-naive had promising results when using dolutegravir/lamivudine as antiretroviral therapy over 48 weeks.

Engaging migrants in HIV care can help to meet the United Nations’ 95-95-95 goal in Australia.

Increasing testing for both HIV and sexually transmitted infections (STIs) can help to mitigate the incidence of both in high school students.

HIV infections and deaths would increase dramatically should the United States cut back on funding for the President’s Emergency Plan for AIDS Relief (PEPFAR).

An overall increase in life expectancy was observed across all individuals living with HIV but disparities between gender groups persist.

Women living in rural Appalachia who are at high-risk of HIV had effective interventions delivered through Facebook.

Pharmacy students primarily in the US had a shortage of tools to assess knowledge specifically of prophylaxis in HIV care.

Patients living with HIV who were frail or prefrail had significantly poorer oral health-related quality of life compared with patients with HIV who were robust.

In patients with HIV, alcohol reduction after a 6-month intervention and adherence to isoniazid had no effect on the high levels of viral suppression reported at baseline.

A meta-analysis found a low risk of HIV transmission in people taking antiretroviral therapy (ART) in high-income countries.

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, confirming phase 3 testing results.

Women who are using heroin and were recently incarcerated had increased stimulant use, which is associated with adverse outcomes in HIV.

Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was high.

Men who have sex with men (MSM) can now participate in National Blood Donor Month under the FDA's updated guidelines, marking a crucial step toward addressing blood shortages and promoting inclusivity.

Interventions, such as asset-building, differential service delivery interventions, and digital interventions can help to improve health outcomes in adolescents with HIV.

Monitoring thyroid dysfunction from HIV could prevent hypothyroidism in the few patients who have these abnormalities.

People living with HIV in California were highly satisfied with telephone visits during the height of the COVID-19 pandemic and wanted to continue them in their regular care.

Lockdowns instituted due to the COVID-19 pandemic could have brought about exacerbated immune responses in people living with HIV.

Top articles about HIV this year included effects of HIV on tooth loss and cardiac surgery, caregiver experiences, and a federal ruling on military enlistment.

The prevalence of HPV81 in mother-child pairs with HIV in Nigeria could have implications on vaccination against human papillomavirus (HPV).

Stigma surrounding HIV can lead to barriers to health care, including refusal to get care, that could help individuals who are living with the condition.

Symptoms associated with long COVID were less frequent in patients living with HIV.

Tailored promotion of testing for HIV and sexually transmitted infections can help to reduce the incidence of HIV in adolescents.

Older adults with HIV provided insights into their preferences and experiences with virtual care to provide areas to target in practice and policy.

A qualitative study spoke to emergency department and HIV clinic staff to evaluate the feasibility of initiating pre-exposure prophylaxis (PrEP) in patients visiting the emergency department.

Women with higher symptoms of post-traumatic stress disorder and major depressive disorder after intimate partner violence were more likely to have higher motivation to receive pre-exposure prophylaxis (PrEP).

Women living with HIV can reduce their risk of cervical cancer using a human papillomavirus (HPV) vaccine that is both cost-effective and effective in preventing the virus.

An update from the PURPOSE 2 trial focused on adherence and pharmacokinetics data for lenacapavir, used to prevent HIV.

The combination therapy of bictegravir/emtricitabine/tenofovir (BIC/FTC/TAF) was both tolerable and produced virologic suppression in patients who were presenting late in their HIV infection.

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver conditions are prevalent for these individuals.